Gordon Dunn

Insider Reports History

Location
Ter Aviv, Israel
Signature
/s/ Gordon Dunn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gordon Dunn:

Form 4 holding Chief Financial Officer

Quoin Pharmaceuticals, Ltd.

Security class
Ordinary Shares
Shares / value
151,077
Estimated value
$67,985
Report date
23 Dec 2024
Price
$0.4500
Ownership
Direct
Form 4 holding Chief Financial Officer

Quoin Pharmaceuticals, Ltd.

Security class
Share Option (Right to Buy)
Shares / value
338,994
Estimated value
Report date
09 Dec 2024
Price
Ownership
Direct
Underlying class
ADS
Underlying amount
Form 4 holding Chief Financial Officer

Quoin Pharmaceuticals, Ltd.

Security class
Series F Warrants (right to buy)
Shares / value
122,221
Estimated value
Report date
23 Dec 2024
Price
Ownership
Direct
Underlying class
ADS
Underlying amount
Form 4 holding Chief Financial Officer

Quoin Pharmaceuticals, Ltd.

Security class
Series G Warrants (right to buy)
Shares / value
122,221
Estimated value
Report date
23 Dec 2024
Price
Ownership
Direct
Underlying class
ADS
Underlying amount

Insider Reports Filed by Gordon Dunn

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .